Create an Account
  1. Home
  2. Specialty
  3. Optometry

Emergent Pharmaceutical Treatments for Dry Eye Diseases

Emergent Pharmaceutical Treatments for Dry Eye Diseases
Media formats available:
Details
Presenters

  • Overview

    In this video, Drs. Bloomenstein and Brujic describe first-line treatments for patients with dry eye as well as strategies to address their inflammation and tips on educating these patients. You will learn how pharmaceutical management differs from mechanical management and the potential of new and emerging pharmaceutical treatments.

    This activity is supported by unrestricted educational grants from Alcon, Bausch + Lomb, Johnson & Johnson Vision, RVL, Sight Sciences, Tarsus, Théa Pharma, and Trukera Medical.

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Describe specific steps to apply new and emerging therapeutic options and protocols to various types of ocular surface disease (OSD) patients

    • Accreditation

      Sponsored by  

      Evolve Medical Education, LLC is a COPE-accredited administrator. 
      This activity, COPE Activity Number 125673, is accredited by COPE for continuing education for optometrists. This course is approved for 0.25 hours of CE.
      Course #: 83651-TD
      Activity #: 125673

      COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

    • Faculty and Disclosures

      Marc R. Bloomenstein, OD, FAAO

      Marc R. Bloomenstein, OD, FAAO

      Schwartz Laser Eye Center
      Director of Optometric Services
      Scottsdale, AZ


      Mile Brujic, OD, FAAO

      Mile Brujic, OD, FAAO

      Premier Vision Group
      Bowling Green, OH


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.

      The following faculty/staff members have the following financial relationships with ineligible companies.

      Marc R. Bloomenstein, OD, FAAO,has had a financial relationship or affiliation with the following ineligible companies in the form of Consultant: Allergan/AbbVie, Avagen, Bausch + Lomb, BioTissue, Bruder, Dompé, Johnson & Johnson Vision, OcuSoft, Reichert, Sight Sciences, Staar Surgical, Sun Pharmaceutical Industries, Tarsus, Théa Pharma, and Visus. Speaker’s Bureau: Alcon, Allergan/AbbVie, Bausch + Lomb, Dompé, Johnson & Johnson Vision, Sight Sciences, and Sun Pharmaceutical Industries.

      Mile Brujic, OD, FAAO, has had a financial relationship or affiliation with the following ineligible companies in the form of speaking, writing, participating in an advisory capacity, research or meeting support from: ABB Optical, Alcon Laboratories, Aldeyra, Allergan, Apellis, Art Optical, Avellino, Bausch + Lomb Health, Contamac, CooperVision, CSEye, Dompé, Horizon Therapeutics, Johnson & Johnson Vision Care, Kala Pharmaceuticals, Lenstech, Notal Vision, Novartis, Optovue, Oyster Point Pharma, Quidel, RVL, Sun Pharmaceutical Industries, Tangible Science, Santen, Visus, Walman Optical, and Zea Vision.

      The Evolve staff, planners and peer reviewer have no financial relationships with ineligible companies.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group, Alcon, Bausch + Lomb, Johnson & Johnson Vision, RVL, Sight Sciences, Tarsus, Théa Pharma, or Trukera Medical.

      This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Release Date:

      Expiration Date:

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    LIVE ON REACHMD RADIOBack to live radio
    ReachMD Radio

    Loading...

    00:00
    00:00
      Register

      We're glad to see you're enjoying Evolve Medical Education…
      but how about a more personalized experience?

      Register for free